Astrana Health, Inc.
About Astrana Health, Inc.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $3.2B
- Net income
- $22.5M
- Total assets
- $2.2B
- Market cap
- $1.9B
- Operating margin
- 2.5%
- Net margin
- 0.8%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $3.2B
- Operating expenses
- $3.1B
- Operating income
- $78.5M
- Income tax
- $15.5M
- Net income
- $24.1M
- EPS (basic)
- $0.46
- EPS (diluted)
- $0.46
Balance sheet
- Total assets
- $2.2B
- Current assets
- $863.3M
- Total liabilities
- $1.7B
- Current liabilities
- $615.3M
- Shareholders’ equity
- $793.3M
Cash flow
- Operating cash flow
- $114.6M
- Investing cash flow
- -$539.0M
- Financing cash flow
- $569.3M
- Net cash flow
- $144.9M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $1.9B
- P/E ratio
- 83.5
- EPS (diluted)
- $0.46
- Shares outstanding
- 49.1M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Nov 26, 2007
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Profitable — net income of $22.5M in FY2025.
- Revenue grew 56% from FY2024 to FY2025.
- Trading near its 52-week high.
- Valued at a price-to-earnings (P/E) ratio of 83.5.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Astrana Health, Inc..
Write a review
News about Astrana Health, Inc.
News & sentiment via Polygon.io
